Mr. David A. Chazanovitz This is Me

Education

 View all 436 references Web References

1. 1. Inovise::

   www.audicor.com/corporate/boar - [Cached]

   Published on: 6/27/2008   Last Visited: 6/27/2008

   David A. Chazanovitz, ChairMr. Chazanovitz is President and CEO Alveolus, Inc., a leader in the development of non-vascular interventional stent technology.He served as Chief Executive Officer of Cambridge Heart, Inc. from 2001 through October 2006 and as Chairman of the Board of Directors from July 2004 to October 2006.From 1998 to September 2000, Mr. Chazanovitz served as the President of the Neurosciences Division of NMT Medical Inc..From 1996 to July 1998, Mr. Chazanovitz served as the President of the Septal Repair Division of NMT, following the merger of Innerventions, Inc. with NMT.Mr. Chazanovitz was a founder in 1995 of Innerventions, a developer of septal repair devices.Mr. Chazanovitz also previously served as the President of several divisions of C.R. Bard, Inc., including Bard Ventures, Bard Electrophysiology and USCI Angiography.He also serves as a member of the Board of Directors of MedicalCV, Inc (OTCBB:MCVI).

2. 2. www.sec.gov

   www.sec.gov/Archives/edgar/dat - [Cached]

   Published on: 9/11/2007   Last Visited: 9/12/2007

   David A. Chazanovitz(2)
   ...
   David A. Chazanovitz, one of our directors since January 2007, is an executive consultant who served as Chief Executive Officer of Cambridge Heart, Inc. from February 2001 through October 2006 and as the President and a director of Cambridge Heart from October 2000 through October 2006, including service as Chairman from July 2004 to October 2006.Cambridge Heart is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease, including the use of technology to identify those at risk of sudden cardiac death.From July 1998 to September 2000, Mr. Chazanovitz served as the President of the Neurosciences Division of NMT Medical Inc., a medical device firm.From June 1996 to July 1998, Mr. Chazanovitz served as the President of the Septal Repair Division of NMT, following the merger of Innerventions, Inc. with NMT.Mr. Chazanovitz was a founder in 1995 of Innerventions, a developer of septal repair devices.Mr. Chazanovitz also previously served as the President of several divisions of C.R. Bard, Inc., a medical products firm, including Bard Ventures, Bard Electrophysiology and USCI Angiography.Mr. Chazanovitz currently serves as a director of INOVISE Medical, Inc., an emerging growth medical device firm specializing in the combined use of ECG and acoustic cardiography to diagnose conditions of the heart.

3. 3. Management & Board of Directors

   www.fralex.com/Default.aspx?id - [Cached]

   Published on: 6/30/2008   Last Visited: 6/30/2008

   David Chazanovitz - Director of the Company Mr. Chazanovitz currently serves as President & CEO and a Director of Alveolus, Inc., a medical device company dedicated to the development and commercialization of non-vascular stents.Previously, he served as Chief Executive Officer of Cambridge Heart, Inc. (CAMH:OTCBB) from February 2001 through October 2006 and as the President and a director of Cambridge Heart from October 2000 through October 2006, including service as the Chairman of the Board of Directors from July 2004 to October 2006.Cambridge Heart is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease.From July 1998 to September 2000, Mr. Chazanovitz served as the President of the Neurosciences Division of NMT Medical Inc., a medical device firm.From June 1996 to July 1998, Mr. Chazanovitz served as the President of the Septal Repair Division of NMT, following the merger of Innerventions, Inc. with NMT.Mr. Chazanovitz was a founder in 1995 of Innerventions, a developer of septal repair devices.Mr. Chazanovitz also previously served as the President of several divisions of C.R. Bard, Inc., a medical products firm.Mr. Chazanovitz currently serves as the Chairman of the Board of Inovise Medical, Inc., a privately held Portland, Oregon-based company utilizing heart sounds and electrocardiographic information as a diagnostic instrument for the benefit of heart failure patients.Additionally, he serves as a Board member for MedicalCV, Inc., (MCVI:OTCBB) a publicly held company based in Minneapolis, MN, which is engaged in solutions for atrial fibrillation.